Product Image

Wild Alaskan Fish Oil Peak Omega-3 Liquid Natural Lemon Flavor

Wiley's Finest
4.9
★ ★ ★ ★ ★
(1119 ratings)
EPA (Eicosapentaenoic Acid) 1300 mg
Omega-3 250 mg
Fish Oil 4500 mg
DHA 850 mg
Product Image
Score84
A high-potency liquid delivers substantial EPA and DHA without requiring several capsules. Measuring accuracy, premium serving cost, and missing quality-control details are the trade-offs.
How scoring works
Quantity:8 Liquid(s) • (50 servings)
Goals:
Heart Health
Anti-Inflammatory Support
Cardiovascular Support
Mental Focus

Score 84

A high-potency liquid delivers substantial EPA and DHA without requiring several capsules. Measuring accuracy, premium serving cost, and missing quality-control details are the trade-offs.
How scoring works
$52.79($1.05 per serving)
Pure Formulas
$ 52.79
iHerb
$ 52.79
Vitacost
$ 58.05
Vitacost
$ 58.05
Walmart
$ 52.79
Report prices

Analysis

A measured serving supplies 1,300 mg of EPA, 850 mg of DHA, and 250 mg of other omega-3 fats. The balanced but EPA-led profile is substantial enough for users who want more than basic maintenance.

Liquid delivery can help people who dislike swallowing multiple softgels, and the lemon flavor may improve usability. The chemical form, added antioxidant protection, and independent purity testing are not identified in the supplied label details.

The product fits adults seeking a high-potency liquid for cardiovascular or inflammatory support. Careful measurement matters because the serving is large, and value is weaker for users who need only a modest daily amount.

Who is it for
  • Adults seeking high-potency liquid omega-3
  • People who dislike large or multiple softgels
  • Users targeting both EPA and DHA
Best for
  • Intensive omega-3 supplementation
  • EPA-led cardiovascular support
  • Liquid dosing preferences

Pros

  • Provides 1,300 mg of EPA
  • Provides 850 mg of DHA
  • Supplies 2,400 mg of total omega-3 fats
  • Liquid format avoids multiple capsules

Cons

  • Requires careful liquid measurement
  • Molecular form is not stated
  • No antioxidant protection is listed
  • Independent purity verification is not supplied
  • Premium serving cost

Warnings

  • Contains fish oil and is not suitable for people with a fish allergy
  • Fish oil may cause fishy aftertaste, reflux, or digestive discomfort in sensitive users
  • The substantial EPA and DHA amount may be relevant for people using anticoagulant or antiplatelet medicines

Nutrient quality

87 Highest impact

Concentrated wild Alaskan liquid fish oil with an unspecified molecular form gives the formula reasonable ingredient quality. The disclosed amounts are meaningful and the ingredient selection stays focused.

Ingredient transparency

86 Highest impact

The meaningful actives and their amounts are clearly identified. Serving guidance and the complete inactive-ingredient list are not fully supplied.

Customer satisfaction

72 High impact

The aggregate rating is strong and supported by useful review volume. No review excerpts are supplied to assess repeated complaints or purpose-specific experiences.

Value for money

88 Highest impact

Formula quality provides fair value for the category. The effective serving and focused ingredient list compare favorably with similar options.

Report analysis

Goals

Heart Health
Impact
Highest effect
A+ Goal FitA Strength of SupportB- CoverageA+ Formula Quality
EPA (Eicosapentaenoic Acid) · 1300 mg

The serving provides 1300 mg EPA and 850 mg DHA, creating a strong heart-relevant omega-3 profile. EPA-led omega-3 intake is well aligned with triglyceride management and inflammatory balance.

Individual active amounts are transparent, but the molecular form, oxidation protection, and independent purity testing are not disclosed. Liquid delivery allows a concentrated serving without unnecessary companion actives.

Study evidence
Anti-Inflammatory Support
Impact
Highest effect
A+ Goal FitB+ Strength of SupportB+ CoverageA Formula Quality
Fish Oil · 4500 mg

A combined 2,150 mg of EPA and DHA provides high-potency support for the body’s inflammation-resolving pathways. The liquid supplies both fatty acids at clearly disclosed amounts.

The molecular form, purification process, independent testing, and oxidation protection are not stated. Those omissions matter more for a concentrated liquid oil that can be exposed to air after opening.

Study evidence
Fish Oil Supportive 68 studies
Cardiovascular Support
Impact
Highest effect
A+ Goal FitB+ Strength of SupportB- CoverageA+ Formula Quality
Fish Oil · 4500 mg

The liquid provides 1,300 mg EPA and 850 mg DHA, a substantial dose that directly supports triglyceride management and cardiovascular inflammation pathways. Separate fatty-acid amounts and Wild Alaskan sourcing are useful strengths.

The oil is less concentrated than the capsule product, and its molecular form, purification, independent testing, and oxidation protection are not disclosed. Higher-dose fish oil may increase bruising or bleeding risk with anticoagulant or antiplatelet medicines.

Study evidence
Fish Oil Supportive 185 studies
Mental Focus
Impact
Highest effect
C+ Goal FitA Strength of SupportC+ CoverageA+ Formula Quality

The liquid fish oil delivers substantial EPA and DHA that may support mood, membranes, and the brain environment. Benefits for concentration would be gradual and indirect rather than immediately stimulating.

The high fatty-acid amounts provide excellent depth and are fully disclosed. The formula remains narrow because it does not include a direct alertness, neurotransmitter, or stress-resilience active.

Study evidence

Ingredients

IngredientAmount per serving
Calories
41 {Calories}
Calories from Fat
41 {Calories}
Total Fat
4.5 Gram(s)
Saturated Fat
0 Gram(s)
Polyunsaturated Fat
3.2 Gram(s)
Trans Fat
0 Gram(s)
Cholesterol
10 mg
concentrated Fish Oil
4500 mg
Eicosapentaenoic Acid
1300 mg
Docosahexaenoic Acid
850 mg
Other Omega-3 Fatty Acids
250 mg
Gluten Free Adults 18–50 Dairy Free Sugar Free
Report overview
D- Active Ingredient Quality & BioavailabilityB+ Dose, Safety & Label TransparencyB+ Value

A very high EPA dose and EPA-led ratio suit users seeking a concentrated liquid option. Molecular form, antioxidant protection, and independent purity testing are not disclosed, while EPA density within the total oil is only moderate. Cost per gram of EPA is fair despite a high serving cost.

Omega-3 · 250 mg OverallScore59
D- Active Ingredient Quality & BioavailabilityC- Dose, Safety & Label TransparencyA+ Value

The liquid provides clearly separated EPA and DHA amounts, but their concentration is modest relative to the total oil. Its concentrate designation suggests an ethyl ester form, and no antioxidant or third-party purity evidence is stated. The large active serving nevertheless gives highly economical EPA and DHA.

Fish Oil · 4500 mg OverallScore52
F Active Ingredient Quality & BioavailabilityB Dose, Safety & Label TransparencyB+ Value

Wild Alaskan sourcing and a 2,150 mg combined EPA and DHA dose make the active profile compelling. The molecular form, purification process, independent testing, and antioxidant protection are not disclosed. Cost efficiency is favorable for the active amount supplied.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Dose-dependent effects of fish oil on cardio-metabolic biomarkers in healthy middle-aged and elderly Chinese people: a double-blind randomized controlled trial.
    Song J; Hu M; Li C; Yang B; Ding Q; Wang C; Mao L · Food & function · 2018
    Randomized trial201 participantsAnti-Inflammatory Support forFish Oil
  2. Eicosapentaenoic acid supplementation alleviates pruritus, enhances skin moisture, and mitigates depression in maintenance hemodialysis patients.
    Lin YL; Wang CL; Chiang TI · Frontiers in nephrology · 2024
    Randomized trial60 participantsAnti-Inflammatory Support forFish Oil
  3. Lowering effects of fish oil supplementation on proinflammatory markers in hypertension: results from a randomized controlled trial.
    Yang B; Ren XL; Li ZH; Shi MQ; Ding F; Su KP; Guo XJ; Li D · Food & function · 2020
    Randomized trial77 participantsAnti-Inflammatory Support forFish Oil
  4. The effects of ω-3 fish oil emulsion-based parenteral nutrition plus combination treatment for acute paraquat poisoning.
    Meng Z; Dong Y; Gao H; Yao D; Gong Y; Meng Q; Zheng T; Cui X; Su X; Tian Y · The Journal of international medical research · 2019
    Randomized trial174 participantsAnti-Inflammatory Support forFish Oil
  5. Effects of Omega-3 Fatty Acid Intake in Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Liu R; Jiang J; Fu Z; Liu C; Yao L; Quan H · Journal of the American Nutrition Association · 2022
    Meta-analysis49 studies pooledAnti-Inflammatory Support forFish Oil
  6. Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
    Hu Y; Hu FB; Manson JE · Journal of the American Heart Association · 2020
    Meta-analysis127,477 participants13 studies pooledCardiovascular Support forFish Oil
  7. Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
    Lu J; Liu R; Ren H; Wang S; Hu C; Shi Z; Li M; Liu W; Wan Q; Su Q; Li Q; Zheng H; Qu S; Yang F; Ji H; Lin H; Qi H; Wu X; Wu K; Chen Y; Xu Y; Xu M; Wang T; Zheng J; Ning G; Zheng R; Bi Y; Zhong H; Wang W · Med (New York, N.Y.) · 2025
    Randomized trial309 participantsCardiovascular Support forFish Oil
  8. A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
    Campbell F; Dickinson HO; Critchley JA; Ford GA; Bradburn M · European journal of preventive cardiology · 2013
    Meta-analysis1,524 participants17 studies pooledCardiovascular Support forFish Oil
  9. Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
    Zeng Q; Dong SY; Liu YP; Fu J; Shuai P; Zhao ZM; Li TX · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2017
    Randomized trial422 participantsCardiovascular Support forFish Oil
  10. Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Sekikawa A; Cui C; Sugiyama D; Fabio A; Harris WS; Zhang X · Nutrients · 2020
    Meta-analysis6 studies pooledCardiovascular Support forFish Oil
  11. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
    Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Saito Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Japan EPA lipid intervention study (JELIS) Investigators · Lancet (London, England) · 2007
    Randomized trial18,645 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  12. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
    Saito Y; Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; JELIS Investigators, Japan · Atherosclerosis · 2008
    Randomized trial14,981 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  13. Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
    Dinu M; Sofi F; Lotti S; Colombini B; Mattioli AV; Catapano AL; Casula M; Baragetti A; Wong ND; Steg PG; Ambrosio G · European journal of preventive cardiology · 2024
    Meta-analysis134,144 participants18 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  14. Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease.
    Matsuzaki M; Yokoyama M; Saito Y; Origasa H; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Matsuzawa Y; JELIS Investigators · Circulation journal : official journal of the Japanese Circulation Society · 2009
    Randomized trialHeart Health forEPA (Eicosapentaenoic Acid)
  15. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
    Skulas-Ray AC; Wilson PWF; Harris WS; Brinton EA; Kris-Etherton PM; Richter CK; Jacobson TA; Engler MB; Miller M; Robinson JG; Blum CB; Rodriguez-Leyva D; de Ferranti SD; Welty FK; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology · Circulation · 2020
    OtherHeart Health forEPA (Eicosapentaenoic Acid)
  16. The influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysis.
    Suh SW; Lim E; Burm SY; Lee H; Bae JB; Han JW; Kim KW · BMC medicine · 2024
    Meta-analysis9,660 participants24 studies pooledMental Focus forEPA (Eicosapentaenoic Acid)
  17. EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD.
    Gustafsson PA; Birberg-Thornberg U; Duchén K; Landgren M; Malmberg K; Pelling H; Strandvik B; Karlsson T · Acta paediatrica (Oslo, Norway : 1992) · 2011
    Randomized trial92 participantsMental Focus forEPA (Eicosapentaenoic Acid)
  18. Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)-Should They Be Mandatory Supplements in Pregnancy?
    Amza M; Haj Hamoud B; Sima RM; Dinu MD; Gorecki GP; Popescu M; Gică N; Poenaru MO; Pleș L · Biomedicines · 2024
    Narrative reviewMental Focus forEPA (Eicosapentaenoic Acid)
  19. Supplementation with oil rich in eicosapentaenoic acid, but not in docosahexaenoic acid, improves global cognitive function in healthy, young adults: results from randomized controlled trials.
    Patan MJ; Kennedy DO; Husberg C; Hustvedt SO; Calder PC; Khan J; Forster J; Jackson PA · The American journal of clinical nutrition · 2021
    Randomized trial310 participantsMental Focus forEPA (Eicosapentaenoic Acid)